Shuhong Wu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 2

Top Topics

Epstein Barr Virus

Intensive Care Unit

Mesenchymal Stem Cells

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Haniel A Araujo, Ximo Pechuan, Teng Zhou, Minh Truong Do, Xin Hu, Frank R Rojas Alvarez, Maria E Salvatierra, Heladio P Ibarguen, Richard Lee, Rashi Raghulan, Harshit Shah, Mariela A Moreno Ayala, Kevin Chen, Nataliya Tovbis Shifrin, Shuhong Wu, Luisa Maren Solis Soto, Marcelo Vailati Negrão, Don L Gibbons, David S Hong, Jack A Roth, John Victor Heymach, Jianjun Zhang, Jingjing Jiang, Mallika Singh, Jacqueline A M Smith, Elsa Quintana, Ferdinandos Skoulidis
Mechanisms of response and tolerance to active RAS inhibition in KRAS-mutant NSCLC. Cancer discovery (2024)
Xiaoshan Zhang, Ran Zhang, Chenghui Ren, Yi Xu, Shuhong Wu, Carrie Meng, Apar Pataer, Xingzhi Song, Jianhua Zhang, Yixin Yao, Hua He, Huiqin Chen, Wencai Ma, Jing Wang, Funda Meric-Bernstam, Richard E Champlin, John V Heymach, Cliona M Rooney, Stephen G Swisher, Ara A Vaporciyan, Jack A Roth, M James You, Michael L Wang, Bingliang Fang
Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo. Blood advances (2021)